(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IMUPHARM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IMUPHARM

ST13

US500000075147432

Class

5

Filing

75147432

Registration

2464058

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

10/06/2021

Trademark type

Word

Nice classes

5

Filing date

08/09/1996

Registration date

06/26/2001

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/06/2021

Last transaction

10/06/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/01/2000

First use in commerce

04/01/2000

Drawing code

1

Owner type

03

Owner location

HAMILTON, BM

Examiner

BUSH, KAREN

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

IMUPHARM LTD
I. C. (pessoa física)

Representatives

John E. Ottaviani Partridge Snow & Hahn LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations for use in the treatment of cancer and immunological disorders and staining agents for clinical medical use in the diagnosis of immunological disorders

Publications

History of USPTO decisions and trademark events.

39 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/06/2021

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

10/06/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/06/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/06/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

06/01/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/26/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/14/2014

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/14/2014

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/28/2011

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/28/2011

E89R

TEAS SECTION 8 & 9 RECEIVED

06/24/2011

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/31/2010

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/01/2007

PLGL

ASSIGNED TO PARALEGAL

07/19/2007

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

06/25/2007

E815

TEAS SECTION 8 & 15 RECEIVED

06/25/2007

CFIT

CASE FILE IN TICRS

10/11/2006

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/26/2004

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/08/2003

R.PR

REGISTERED-PRINCIPAL REGISTER

06/26/2001

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/30/2001

DOCK

ASSIGNED TO EXAMINER

01/30/2001

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/23/2001

IUAF

USE AMENDMENT FILED

05/16/2000

EX5G

SOU EXTENSION 5 GRANTED

02/15/2000

EXT5

SOU EXTENSION 5 FILED

12/20/1999

EX4G

SOU EXTENSION 4 GRANTED

07/30/1999

EXT4

SOU EXTENSION 4 FILED

06/29/1999

EX3G

SOU EXTENSION 3 GRANTED

01/22/1999

EXT3

SOU EXTENSION 3 FILED

12/23/1998

EX2G

SOU EXTENSION 2 GRANTED

06/26/1998

EXT2

SOU EXTENSION 2 FILED

06/26/1998

EX1G

SOU EXTENSION 1 GRANTED

02/20/1998

EXT1

SOU EXTENSION 1 FILED

01/06/1998

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

07/08/1997

PUBO

PUBLISHED FOR OPPOSITION

04/15/1997

NPUB

NOTICE OF PUBLICATION

03/14/1997

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/13/1997

DOCK

ASSIGNED TO EXAMINER

01/23/1997

Continuous trademark protection

Get notified about every new filing that threatens IMUPHARM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.